Brooke Boyarsky Pratt and Vineeta Agarwala discuss obesity medicine, patient-centric care, and the future of metabolic health. They explore the role of GLP-1s, personalized approaches in obesity management, and the safety of GLP-1 receptor agonists. The episode also highlights the importance of courage and bold decisions for founders in the healthcare industry.

Brooke Boyarsky Pratt, CEO of knownwell, discusses obesity medicine, patient-centric care, and the future of metabolic health. Topics include GLP-1s for insulin regulation, improving patient access to medications, and the founder's transition from business to healthcare passion.

Brooke Boyarsky Pratt, the founder and CEO of KnownWell, and Jon Jachimowicz, an assistant professor at Harvard Business School, engage in a heartfelt discussion about addressing obesity care. They explore Brooke’s personal battle with weight stigma and her mission to create an inclusive healthcare option. The duo weighs the challenges of scaling her venture against personal passion and the intricacies of navigating career transitions. They also touch on the stigma surrounding obesity in healthcare and the emotional toll of starting a new chapter in one's career.